WebNov 8, 2024 · Jefferies has downgraded its rating on shares of Divi's Laboratories to 'hold' following the Q2 revenue and EBITDA miss as compared to its estimates. Pfizer's COVID oral drug candidate Paxlovid shows the efficacy of 89 percent, which could pose a threat to Divi's Laboratories' Molnupiravir prospects. Jefferies said the stock is trading at an ... WebNov 8, 2024 · Divi's Laboratories maintained stable EBIT margins over the last year, all while growing revenue 29% to ₹93b. That's a real positive. The chart below shows how the company's bottom and top lines have progressed over time. For finer detail, click on the image. NSEI:DIVISLAB Earnings and Revenue History November 8th 2024.
DIVISLAB Stock Price and Chart — NSE:DIVISLAB — TradingView
Web2 days ago · The 30-share BSE Sensex climbed 125 points or 0.21 per cent to trade at 60,283, while the broader NSE Nifty moved 51 points or 0.29 per cent higher to trade at 17,773. ... Divi's Lab was the top ... WebApr 3, 2024 · F&O Quote of Divis Lab Share Price, Future and Options Divis Lab Live BSE, NSE Charts, historical charts, F&O Quote, Stock quote of Divis Lab, Divis Lab … shots common
divi
Web2 days ago · Dr Reddy’s Laboratories. Shares of Dr Reddy’s Laboratories ended among top gainers on Nifty50 on Wednesday. The stock rose nearly 2.22 per cent to Rs 4,869 … WebYour technical analysis summary for DIVI'S LABORATORIE. This gauge displays a real-time technical analysis overview for your selected timeframe. The summary of DIVI'S LABORATORIE is based on the most popular technical indicators, such as Moving Averages, Oscillators and Pivots. Learn more . WebApr 12, 2024 · BOM : 532488 NSE : DIVISLAB : LT : Long Term Analysis ... SHARE PRICE MOMENTUM OF DIVIS LABORATORIES . ... Is DIVIS LABORATORIES trading at a Premium or Discount? As on Apr 12,2024, DIVIS LABORATORIES is trading at a Premium of 26% based on the estimates of Median Intrinsic Value! sarnia south africa